A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...

Can catching brain diseases earlier lead to better treatment? It’s the central question in a new landmark study being ...

A new study has revealed a group of blood proteins that are altered in people who go on to develop multiple sclerosis (MS), in some cases more than a decade before diagnosis. The findings offer hope ...

An experimental method developed to detect nerve injury in multiple sclerosis (MS) in adults also works for children with MS and other neurological conditions, even when they are symptom-free, ...

A new study identifies blood protein alterations, including DKKL1, that predict multiple sclerosis risk a decade before ...

Multiple sclerosis goes undetected because its early symptoms mimic common problems. It is highly under-diagnosed in India.

Researchers have created a blood test to detect multiple sclerosis (MS) patients' immunological responses, which may help us understand and treat the disease. Around 2.8 million individuals worldwide ...

Between the Canadian and U.S. National MS Society, which are co-ordinating efforts, more than $2.4 million has been committed to support seven new research projects on chronic cerebrospinal venous ...

Multiple Sclerosis can occur at any age, but most commonly affects young adults between 20 and 40 years of age ...

On World Multiple Sclerosis Day be warned hat blurred vision and eye pain may be early signs of the undiagnosed neurological disease.

Share on Pinterest Scientists are trying to find blood biomarkers that may help predict the course of disease in MS. Betsie Van der Meer/Getty Images As of 2020, about 2.8 million people globally have ...